US2006258005A1PendingUtilityA1
Novel virus vector
Est. expiryFeb 17, 2023(expired)· nominal 20-yr term from priority
Inventors:Tadanori MayumiShinsaku NakagawaYasuo TsutsumiKoichi KawasakiMitsuko MaedaTakao HayakawaHiroyuki Mizuguchi
A61K 48/00C12N 15/86C12N 2810/405C12N 2710/10343
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There is provided a virus vector characterized in that a water-soluble polymer is directly or indirectly linked to a surface of a virus particle and a heterogeneous peptide having an affinity for integrin present on a surface of a target cell is linked to the water-soluble polymer.
Claims
exact text as granted — not AI-modified1 . A virus vector, characterized in that a water-soluble polymer is directly or indirectly linked to a surface of a virus particle and a heterogeneous peptide having an affinity for integrin present on a surface of a target cell is linked to the water-soluble polymer.
2 . The virus vector according to claim 1 , wherein said water-soluble polymer is linked to the surface of the virus particle via a linker amino acid and a linker.
3 . The virus vector according to claim 1 , wherein said virus is adenovirus.
4 . The virus vector according to claim 1 , wherein said water-soluble polymer is polyethylene glycol or a derivative thereof.
5 . The virus vector according to claim 4 , wherein said polyethylene glycol has a molecular weight of 3000-4000.
6 . The virus vector according to claim 2 , wherein said linker amino acid is cysteine and said linker is one having a linking ability to a thiol group and an amino group.
7 . The virus vector according to claim 6 , wherein said linker is N-(6-maleimidocaproyloxy) succinimide (EMCS).
8 . The virus vector according to claim 1 , wherein said integrin is αV β3 or αVβ5.
9 . The virus vector according to claim 1 , wherein said heterogeneous peptide has a sequence containing arginine(R)-glycine(G)-aspartic acid(D).
10 . The virus vector according to claim 9 , wherein said heterogeneous peptide has a sequence containing one or more of β-alanine.
11 . The virus vector according to claim 9 , wherein said heterogeneous peptide contains lysine (K) and is branched via said lysine.
12 . The virus vector according to claim 11 , wherein said heterogeneous peptide has an amino acid sequence: tyrosine(Y)-glycine(G)-glycine(G)-arginine(R)-glycine(G)-aspartic acid(D)-threonine(T)-proline(P)-β-alanine(X)-lysine(K)-β-alanine(X)-proline(P)-threonine(T)-aspartic acid(D)-glycine(G)-arginine(R)-glycine(G)-glycine(G)-tyrosine(Y).
13 . A method of gene transfer comprising using the virus vector as defined in claim 1 .
14 . A method of production of a virus vector comprising steps of:
a) linking a linker amino acid to one terminal of a water-soluble polymer to obtain a water-soluble polymer-linker amino acid; b) linking a heterogeneous peptide having an affinity for integrin to the water-soluble polymer of the water-soluble polymer-linker amino acid to obtain a heterogeneous peptide-water-soluble polymer-linker amino acid; c) linking a linker to the linker amino acid of the obtained heterogeneous peptide-water soluble polymer-linker amino acid; and d) linking the heterogeneous peptide-water-soluble polymer-linker amino acid with a virus via the linker.
15 . The method of production of a virus vector according to claim 14 , wherein the steps a) and b) are conducted while the linker amino acid is linked to a resin (Resin) and, thereafter, the steps c) and d) are conducted after the produced heterogeneous peptide-water soluble polymer-linker amino acid is cut from the resin.
16 . The method of production of a virus vector according to claim 14 , wherein said water-soluble polymer is polyethylene glycol or a derivative thereof.
17 . The method of production of a virus vector according to claim 14 , wherein said linker amino acid is cysteine and said linker is one having a linking ability to a thiol group and an amino group.
18 . The virus vector according to claim 2 , wherein said virus is adenovirus.
19 . The virus vector according to claim 18 , wherein said water-soluble polymer is polyethylene glycol or a derivative thereof.
20 . The virus vector according to claim 19 , wherein said polyethylene glycol has a molecular weight of 3000-4000.
21 . The virus vector according to claim 20 , wherein said linker amino acid is cysteine and said linker is one having a linking ability to a thiol group and an amino group.
22 . The virus vector according to claim 21 , wherein said linker is N-(6-maleimidocaproyloxy) succinimide (EMCS).
23 . The virus vector according to claim 22 , wherein said integrin is αV β3 or αVβ5.
24 . The virus vector according to claim 23 , wherein said heterogeneous peptide has a sequence containing arginine(R)-glycine(G)-aspartic acid(D).
25 . The virus vector according to claim 24 , wherein said heterogeneous peptide has a sequence containing one or more of β-alanine.
26 . The virus vector according to claim 25 , wherein said heterogeneous peptide contains lysine (K) and is branched via said lysine.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.